Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma
Lindsay DeVorkin, Julian J. Lum(BC Cancer Agency), Matthew Hattersley(BC Cancer Agency), Jenna Ries(BC Cancer Agency), Michael S. Anglesio(University of British Columbia), Jaeline E. Spowart(BC Cancer Agency), Jeffrey D. Winkler(University of Pennsylvania), Anna V. Tinker(BC Cancer Agency), David G. Huntsman(BC Cancer Agency), Samuel M. Levi(University of the Arts), Paul Kim(Profectus Biosciences (United States)), Ravi K. Amaravadi(University of Pennsylvania)
Cited by 60
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
|PLoS Medicine|2010|1.1k
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
|Journal of Clinical Investigation|2007|1.1k